Cancer  /  Economic Value

16 Matching Facts

Search matching Facts:
No results to display
    • Gains in healthy years of life and social value from cancer R&D
       
    • Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.  
    • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
    • Investments in research since the 1970s have generated $1.9 trillion of value to society overall.  
    • Between 2008 and 2010, use of colonoscopy for the treatment and prevention of colon cancer saved an average of $150,364 each year, per person affected.  
    • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.   
    • Low dose CT screening for lung cancer costs less than $200 per person, and surgery for stage I lung cancer is less than 1/2 the cost of late-stage treatment.  
    • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
    • Based on cost-effectiveness consideration, the preferred screening method for colon cancer is a colonoscopy every 10 years after the age of 50.  
    • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).  
    • A drug that can reduce the risk of breast cancer in high-risk women costs approximately $1,050 per year. The average cost per year for surgery or other invasive methods of…  
    • Virtual colonoscopy is more efficient at detecting cancerous polyps than standard colonoscopy without imaging, and costs $500-$1,500 less.  
    • Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349…  
    • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.  
    • Every additional dollar spent on overall breast cancer treatment has produced health gains valued at $4.80.  
    • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…